Susquehanna International Group, LLP Tandem Diabetes Care Inc Call Options Transaction History

Susquehanna International Group, LLP

$560 Billion
Q3 2024

Call Options

26 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q3 2024 Nov 14, 2024	SELL	$35.21 - $47.3 $1.44 Million - $1.94 Million	-41,000 Reduced 31.27%	90,100 $3.82 Million
Q2 2024 Aug 15, 2024	SELL	$30.43 - $53.43 $5.47 Million - $9.61 Million	-179,800 Reduced 57.83%	131,100 $5.28 Million
Q1 2024 May 07, 2024	BUY	$22.09 - $35.41 $4.98 Million - $7.99 Million	225,600 Added 264.48%	310,900 $11 Million
Q4 2023 Feb 14, 2024	SELL	$14.28 - $31.03 $589,764 - $1.28 Million	-41,300 Reduced 32.62%	85,300 $2.52 Million
Q3 2023 Nov 14, 2023	BUY	$19.33 - $36.22 $1.51 Million - $2.84 Million	78,300 Added 162.11%	126,600 $2.63 Million
Q2 2023 Aug 11, 2023	BUY	$24.18 - $42.46 $316,758 - $556,226	13,100 Added 37.22%	48,300 $1.19 Million
Q1 2023 May 16, 2023	BUY	$35.86 - $46.5 $154,198 - $199,950	4,300 Added 13.92%	35,200 $1.43 Million
Q4 2022 Feb 14, 2023	SELL	$35.49 - $56.15 $2.28 Million - $3.6 Million	-64,200 Reduced 67.51%	30,900 $1.39 Million
Q3 2022 Nov 14, 2022	SELL	$43.76 - $68.97 $2.69 Million - $4.24 Million	-61,500 Reduced 39.27%	95,100 $4.55 Million
Q2 2022 Aug 15, 2022	BUY	$53.22 - $123.09 $915,384 - $2.12 Million	17,200 Added 12.34%	156,600 $9.27 Million
Q1 2022 May 16, 2022	SELL	$101.89 - $150.09 $12.9 Million - $19 Million	-126,800 Reduced 47.63%	139,400 $16.2 Million
Q4 2021 Feb 14, 2022	SELL	$118.18 - $153.21 $1.7 Million - $2.21 Million	-14,400 Reduced 5.13%	266,200 $40.1 Million
Q3 2021 Nov 15, 2021	SELL	$93.51 - $129.4 $6.59 Million - $9.12 Million	-70,500 Reduced 20.08%	280,600 $33.5 Million
Q2 2021 Aug 11, 2021	BUY	$77.0 - $100.19 $8.86 Million - $11.5 Million	115,000 Added 48.71%	351,100 $34.2 Million
Q1 2021 May 17, 2021	BUY	$81.28 - $104.34 $3.06 Million - $3.93 Million	37,700 Added 19.0%	236,100 $20.8 Million
Q4 2020 Feb 16, 2021	SELL	$86.4 - $121.75 $13.3 Million - $18.8 Million	-154,100 Reduced 43.72%	198,400 $19 Million
Q3 2020 Nov 16, 2020	BUY	$95.43 - $116.09 $7.92 Million - $9.64 Million	83,000 Added 30.8%	352,500 $40 Million
Q2 2020 Aug 14, 2020	BUY	$60.05 - $98.92 $2.13 Million - $3.51 Million	35,500 Added 15.17%	269,500 $26.7 Million
Q1 2020 May 15, 2020	BUY	$47.37 - $90.04 $2.87 Million - $5.45 Million	60,500 Added 34.87%	234,000 $15.1 Million
Q4 2019 Feb 14, 2020	SELL	$53.13 - $71.19 $1.85 Million - $2.48 Million	-34,900 Reduced 16.75%	173,500 $10.3 Million
Q3 2019 Nov 14, 2019	SELL	$57.11 - $73.3 $12.6 Million - $16.2 Million	-220,400 Reduced 51.4%	208,400 $12.3 Million
Q2 2019 Aug 14, 2019	SELL	$54.41 - $71.7 $5.33 Million - $7.03 Million	-98,000 Reduced 18.6%	428,800 $27.7 Million
Q1 2019 May 15, 2019	BUY	$32.25 - $73.56 $6.01 Million - $13.7 Million	186,300 Added 54.71%	526,800 $33.5 Million
Q4 2018 Feb 14, 2019	SELL	$28.45 - $40.65 $12.3 Million - $17.5 Million	-430,800 Reduced 55.85%	340,500 $12.9 Million
Q3 2018 Nov 14, 2018	BUY	$21.39 - $51.17 $9.4 Million - $22.5 Million	439,600 Added 132.53%	771,300 $33 Million
Q2 2018 Aug 14, 2018	BUY	$4.9 - $23.64 $1.63 Million - $7.84 Million	331,700 New	331,700 $7.3 Million

Others Institutions Holding TNDM

# of Institutions

360

Shares Held

72.5M

Call Options Held

3.36M

Put Options Held

229K

Black Rock Inc. New York, NY

11.1M
Shares

$335 Million
0.01% of portfolio
Vanguard Group Inc Valley Forge, PA

7.36M
Shares

$222 Million
0.01% of portfolio
Capital World Investors Los Angeles, CA

3.27M
Shares

$98.4 Million
0.02% of portfolio
State Street Corp Boston, MA

2.66M
Shares

$80.1 Million
0.0% of portfolio
Arrow Mark Colorado Holdings LLC Denver, CO

2.39M
Shares

$72 Million
1.44% of portfolio

View Full List

About TANDEM DIABETES CARE INC

Ticker TNDM
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 64,221,200
Market Cap $1.94B
Description
Tandem Diabetes Care, Inc., a medical device company, designs, develops, and commercializes various products for people with insulin-dependent diabetes in the United States and internationally. The company's flagship product is the t:slim X2 insulin delivery system, a pump platform that comprises t:slim X2 pump, its 300-unit disposable insulin c...

More about TNDM

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Susquehanna International Group, LLP, based on Form 13F filings with the SEC.

News

Stay updated on Susquehanna International Group, LLP with notifications on news.

Account